Month: September 2022

Roflumilast cream showed higher efficacy compared to vehicle in both Phase 3 studies on the primary efficacy endpoint of Investigator Global Assessment (IGA) success, with 40% of roflumilast cream treated patients achieving IGA success at eight weeks Roflumilast cream also demonstrated statistically significant improvements over vehicle in key secondary endpoints with ~70% of patients achieving Intertriginous-IGA success and ~40% of patients achieving PASI-75 at eight weeks Improvement in itch occurred as early as two weeks and improved consistently through week eight Once-daily ZORYVE™(roflumilast) is approved for topical use in adults and adolescents with plaque psoriasis, including intertriginous psoriasis, regardless of disease severityWESTLAKE VILLAGE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc....

THIS NEWS RELEASE IS NOT FOR DISTRIBUTIONIN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Sept. 20, 2022 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) is pleased to announce the results of the 2022 Annual General Meeting of shareholders that was held on September 20, 2022 in Hong Kong, China. The Company is pleased to report that, as in prior years, a very high shareholder response was achieved, with 88.75% of Century’s outstanding shares having been voted at the meeting.   At that meeting, the shareholders:set the size of the Board of Directors at nine members; elected the Board of Directors; and re-appointed PricewaterhouseCoopers LLP as the Company’s auditors for the upcoming year.Number of Directors The number of directors of the Company for the ensuing year was confirmed...

CARLSBAD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the Lytham Partners Fall 2022 Investor Conference, taking place virtually on September 28-29, 2022. During the event, the company will be participating in a webcasted presentation discussion and conducting 1×1 virtual investor meetings. The Company’s webcast presentation will be a Panel Discussion hosted by Trent Northcutt, President and CEO and Krissy Ramey, National Director of Clinical Education of Aurora Spine. The discussion is titled: Simplifying the Complex – A Panel Discussion with Doctors that use Aurora Products, and will be available...

Infill and extension exploration drill program at La Loutre Graphite Property Beat ExpectationsEV Zone Drill Map 10%+ High Grade Area at EV Zone identifiedVancouver, BC, Sept. 20, 2022 (GLOBE NEWSWIRE) — Montreal, Quebec – September 20, 2022 – Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”) is pleased to announce the second round of analytical results from the infill and extension exploration drill program at its wholly-owned La Loutre Graphite property, located approximately 180 kilometres northwest of Montréal in the Laurentian region of Québec. The La Loutre graphite project site is located within the Kitigan Zibi Anishinabeg (KZA) First Nations territory. The drilling was supervised by Québec-based, independent geological consultant Breakaway Exploration Management Inc. and was operated under...

–6th approved indication of toripalimab in China, bringing more treatment options to patients with advanced NSCLC SHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the China National Medical Products Administration (“NMPA”) has approved the supplemental new drug application (“sNDA”) for toripalimab in combination with pemetrexed and platinum as the first-line treatment in EGFR mutation-negative and ALK mutation-negative, unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer (“NSCLC”). This is the sixth indication approved for toripalimab in China and...

On 20 September 2022, Viru County Court accepted a claim by  Eesti Ühistuenergia OÜ against Enefit Wind Purtse AS, a subsidiary of Enefit Green AS. The claimant requested that wind turbines more powerful than 3 MW shall not be erected in Purtse wind farm. By the court order, Viru County Court granted the claimant’s application for interim relief and prohibited erection of wind turbines more powerful than 3 MW during the court proceedings.  The Management Board of Enefit Green is of the opinion that it has acted lawfully in the construction of the Purtse wind farm and intends to object the claim and challenge the interim relief order. Enefit Green has previously announced its intention to build five wind turbines with a capacity of 4.2 MW in the Purtse wind farm. According to the preliminary assessment of the Management Board of...

The CEO of Galilee Export, the second largest Israeli exporter of fresh fruits and vegetables sees increased demand from EU retailers due to the combination of new EU regulations requiring reduced pesticide residues as well as Save Food’s innovative eco-treatment’s ability to prolong shelf life of fresh fruit. Neve Yarak, IL, Sept. 20, 2022 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W) (“Save Foods” or the “Company”), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, today announced growing interest among European retailers and distributors in Save Foods innovative eco-treatment. Dror Eigerman, CEO of Galilee Export and member of Save Foods’ Advisory Board said “After implementing Save Food’s...

The Meeting resolved that the Board of Directors comprise of five (5) ordinary members and no deputy members, and elected Christian Lagerling as new Board member and Chairman of the Board. The Board of Directors consists of Ted Elvhage, Alexander Kotsinas, Dimitrij Titov, Juan Vallejo and Christian Lagerling. Sofia Bertling and Tomas Mikaelsson have left the Board of Directors, and the Meeting resolved that the fee to resigning Members shall be paid for each commenced calendar month of the term between the AGM and the EGM with 1/12 of the at the AGM 2022 decided (i) board remuneration and (ii) remuneration for committee work. Furthermore, the Meeting resolved that the remuneration to the new Chairman shall be SEK 450,000 (corresponding to 8/12 of the at the AGM 2022 decided remuneration to the Chairman). For further information, please...